Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction
Recruiting
After knee surgery for a torn ACL, many women struggle with weak thigh muscles for years, partly due to reduced brain signals to these muscles. Our research tests a new approach to improve recovery by using low-level brain stimulation to boost these signals. We'll study 42 women, aged 18-35, who had ACL surgery. They'll be split into two groups: one receiving real brain stimulation and another getting a placebo, both during thigh-strengthening exercises. Over six sessions, we'll measure thigh mu... Read More
Gender:
FEMALE
Ages:
Between 18 years and 35 years
Trial Updated:
08/14/2025
Locations: Ryan Zarzycki, Glenside, Pennsylvania
Conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation, Quadriceps Muscle Function
STICH3C Cardiac Magnetic Resonance Observational Study
Recruiting
STICOS will test the hypothesis that residual jeopardized myocardium, late gadolinium enhancement, and non-ischemic substrate after revascularization is associated with postoperative adverse cardiovascular events such as heart failure , readmission, or death. This study will look at whether certain heart tissue abnormalities seen on MRI scans can help predict serious health problems after heart procedures like stents or bypass surgery.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/14/2025
Locations: NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York +8 locations
Conditions: Ischemic Left Ventricle Systolic Dysfunction, Multivessel Coronary Artery Disease
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
Recruiting
The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absorbed, modified, distributed, and removed from the body of the participants) of once-yearly intramuscular for HIV pre-exposure prophylaxis (PrEP) in people with an indication for PrEP. The primary objective of this study is to evaluate the pharmacokinetics (PK) and the safety and tolerability of intramuscular (IM) every 12 months (Q12M) LEN for PrEP... Read More
Gender:
ALL
Ages:
16 years and above
Trial Updated:
08/14/2025
Locations: Mills Clinical Research, Los Angeles, California +2 locations
Conditions: HIV Pre-exposure Prophylaxis
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
Recruiting
The goal of this clinical trial is to determine whether ingestion of a ketone ester drink helps improve liver health and blood glucose control. Ketones are a type of energy source made by the body during times of weight loss, low carbohydrate intake and starvation. People enrolled in this study will be randomly assigned (by chance, like the flip of a coin) to one of two groups: Group 1: Ketone ester drink consumed daily for 6 weeks. Group 2: Placebo drink consumed daily for 6 weeks.
Gender:
ALL
Ages:
Between 18 years and 22 years
Trial Updated:
08/14/2025
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity
Physical Capacity Building for Chronic Stroke
Recruiting
Cardiac rehabilitation is the standard-of-care treatment option for patients with cardiovascular disease and has been shown to improve many aspects critical to patient recovery. Investigators believe that individuals who have had a stroke need to be treated similarly. Investigators will study the effects of a comprehensive modified cardiac rehabilitation program to determine if it can improve some of the physical and psychosocial problems common in survivors of stroke with and without depression... Read More
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
08/14/2025
Locations: Medical University of South Carolina, Charleston, South Carolina
Conditions: Stroke, Post-stroke Depression
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Recruiting
This is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/14/2025
Locations: Seaport Investigator Site, Chino, California +15 locations
Conditions: Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Recruiting
The purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of JNJ-78278343 in combination with JNJ-95298177 in Part 1 (Dose confirmation) of the study and to determine how safe and tolerable the RP2CD is for treatment of participants with metastatic castration-resistant prostate cancer (mCRPC; a stage of prostate cancer where the cancer has spread beyond the prostate and is resistant to hormonal therapy) in Part 2 (Dose expansion) of study.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
08/14/2025
Locations: Florida Cancer Specialists, Sarasota, Florida
Conditions: Prostatic Neoplasms
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Recruiting
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Gender:
ALL
Ages:
Between 18 years and 74 years
Trial Updated:
08/14/2025
Locations: Antelope Valley Clinical Trials, Lancaster, California +8 locations
Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
08/14/2025
Locations: University of Southern California, Los Angeles, California +26 locations
Conditions: Chronic Primary Immune Thrombocytopenia (ITP)
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
Recruiting
This study will use polygenic scores, a tool which describes differences in genetics, to examine effectiveness of beta blocker medication in heart failure patients with ejection fraction of 41-50 percent. The study will also assess beta blockers' effect on the changes in left ventricular end-systolic volume index by MRI.
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
08/14/2025
Locations: Henry Ford Health, Detroit, Michigan
Conditions: Heart Failure, Polygenic Score
TAP Block Timing Study
Recruiting
This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/14/2025
Locations: Weill Cornell Medical College - NewYork-Presbyterian Hospital, NY, New York
Conditions: Bariatric or General Abdominal Surgeries, Bariatric Surgery Patients
Simplified Onboarding in Adults With Type 2 Diabetes
Recruiting
This is an outpatient study testing different starting doses of insulin in participants with type 2 diabetes. Participants will manage their diabetes using the Omnipod M System. The system is comprised of an Omnipod M Pod, an Omnipod M Controller, and will be used with a Dexcom G6 continuous glucose monitoring sensor (CGM). The main objectives of the study are to evaluate the safety and tolerability of different starting doses of insulin using the Omnipod M System. There is a precursory evaluat... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/14/2025
Locations: University of Colorado, Aurora, Colorado +4 locations
Conditions: Type 2 Diabetes Mellitus